FDA NDC Directory · JSON-LD · Markdown

Rybrevant Faspro

NDC 57894-522 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameAMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
Labeler / ManufacturerJanssen Biotech, Inc.
Marketing categoryBiologic License Application · App BLA761484
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsAMIVANTAMAB (3520 mg/22mL)
HYALURONIDASE (HUMAN RECOMBINANT) (44000 mg/22mL)
Marketing started20260213
Package count1

External sources

Source: openFDA. Public-domain (CC0).